A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NCT07006233 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-08-27
Summary
The aim of this project is to learn about how a change in diet will affect sleepiness, quality of life and metabolic health in people living with narcolepsy and idiopathic hypersomnia. The dietary changes we will be testing are well researched and safe in a wide range of patient groups (such as in obesity, type one and two diabetes, cancer and dysfunction related to the nervous system) but has not been researched in conditions of hypersomnolence such as narcolepsy and idiopathic hypersomnia. It is important to test adjunct therapies and lifestyle changes such as dietary interventions to ensure that people living with hypersomnolence have a range of options in addition to medications, to improve their health.
If effective, this project will be tested in more people and may become a part of routine patient care. These dietary approaches have been shown to improve health and quality of life in people living with chronic pain, neurological conditions such as epilepsy and have been shown to be safe in these populations as well as people living with type one diabetes. This is a new area of research for people living with hypersomnolence.
Conditions
- Idiopathic Hypersomnia
- Narcolepsy Type 1 (NT 1)
- Narcolepsy Type 2 (NT2)
Interventions
- BEHAVIORAL
-
Whole Food Ketogenic Diet
Education around immediate changes to improve diet quality and barriers to dietary behaviour change. Participants will consume a whole-food diet focused on improving diet quality based on the NOVA classifications of unprocessed or minimally processed foods/ingredients (removal of NOVA category 4 foods from diet). This group will focus on the consumption of low-energy, nutrient dense whole foods with a targeted carbohydrate intake of 30-50g per day to achieve nutritional ketosis. The WFKD will adjust carbohydrate level for the individual participant to achieve average blood/urinary ketone levels of between 0.5 and 3.0 mmol/L (tested for objective feedback using a mix of urinary ketone sticks and finger prick blood measures).
- BEHAVIORAL
-
Whole Food Diet
Education around immediate changes to improve diet quality and barriers to dietary behaviour change. Participants will consume a whole-food diet focused on improving diet quality based on the NOVA classifications of unprocessed or minimally processed foods/ingredients (removal of NOVA category 4 foods from diet). This diet is high carbohydrate (45-65% of total energy coming from carbohydrate, 20-35% from fat and 15-25% from protein) based on the Australian dietary guidelines focusing on the consumption of low-energy, nutrient dense whole foods. The higher carbohydrate diet reflects current contemporary 'standard care' dietary recommendations as outlined by the National Health and Medical Research Council's Australian Dietary Guidelines, and therefore represents the most appropriate control diet to compare to the effects of the proposed intervention.
Sponsors & Collaborators
-
Woolcock Institute of Medical Research
collaborator OTHER -
University of Sydney
lead OTHER
Principal Investigators
-
Elizabeth A Machan, PhD · University of Sydney
-
Sheila Sivam, PhD; MD; FracP; BSc (Med) · Royal Prince Alfred Hospital and University of Sydney
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-23
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- Australia
Study Locations
More Related Trials
-
Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy
NCT06279247 ·Status: RECRUITING
-
A Change in Diet May Decrease the Negative Consequences of Chronic Sleep Deprivation
NCT00123214 ·Status: COMPLETED ·Phase: NA
-
Narcolepsy Nightmare Study
NCT05709873 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia
NCT02913651 ·Status: COMPLETED
-
Investigation of Clinical Feature and Brain Function in Narcoleptic Patients
NCT03376568 ·Status: UNKNOWN
-
Neurobehavioral Effects of Partial Sleep Deprivation
NCT02128737 ·Status: COMPLETED ·Phase: NA
-
Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
NCT07299097 ·Status: RECRUITING
-
Local Sleep in Idiopathic Hypersomnia
NCT06153615 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Chronic Sleep Restriction
NCT01493661 ·Status: COMPLETED
-
Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy
NCT06531876 ·Status: COMPLETED
-
Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.
NCT05409651 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Role of the Circadian System in Neurological Sleep-wake Disorders
NCT03356938 ·Status: COMPLETED ·Phase: NA
-
Sleep Disorders of Patients With Diseases of the Nervous System
NCT00001664 ·Status: COMPLETED
-
Metabolomics-based Sleepiness Markers
NCT05585515 ·Status: COMPLETED ·Phase: NA
-
Individual Differences in Diabetes Risk: Role of Slow WaveSleep
NCT00989378 ·Status: COMPLETED
-
Assessment of Tiredness During Awake Resection of Intracerebral Tumors
NCT06922487 ·Status: RECRUITING
-
Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
NCT06457945 ·Status: RECRUITING ·Phase: NA
-
Repeated Challenge of Insufficient Sleep: Endothelial Effects
NCT01523535 ·Status: COMPLETED ·Phase: NA
-
Study of the Academic and Professional Course of Narcoleptic Patients (NARCOSCOL-NARCOVITAE)
NCT03765892 ·Status: COMPLETED
-
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
NCT00620659 ·Status: TERMINATED ·Phase: PHASE2
-
Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes
NCT03984058 ·Status: COMPLETED ·Phase: NA
-
Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
NCT02063217 ·Status: COMPLETED ·Phase: NA
-
Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity
NCT00261898 ·Status: TERMINATED ·Phase: PHASE2
-
Neurophysiologic Correlates of Hypersomnia
NCT01719315 ·Status: COMPLETED
-
Effects of Sleep Duration and Architecture on Insulin Sensitivity
NCT01396941 ·Status: COMPLETED ·Phase: NA